Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Trabectedin MeSH Descriptor Data 2026


MeSH Heading
Trabectedin
Tree Number(s)
D03.383.246.619
D03.633.100.531.820.781
Unique ID
D000077606
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077606
Scope Note
A complex structure that includes isoquinolines joined by a cyclic ester; it is a DNA-binding agent and guanine N2 alkylator derived from the marine tunicate, Ecteinascidia turbinata. Trabectedin is used for the treatment of advanced soft-tissue SARCOMA, after failure of ANTHRACYCLINES or IFOSFAMIDE drug therapy.
Entry Term(s)
ET 743
ET-743
Ecteinascidin 743
NSC 684766
Yondelis
Pharm Action
Antineoplastic Agents, Alkylating
Registry Numbers
ID0YZQ2TCP
0
Related Numbers
114899-77-3
Public MeSH Note
2019; TRABECTIDIN was indexed under DIOXOLES and TETRAHYDROISOQUINOLINES 2007-2018; and under ISOQUINOLINES 1996-2018
History Note
2019 (1996)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Trabectedin Preferred
Ecteinascidin 743 Narrower
NSC 684766 Narrower
Yondelis Narrower
page delivered in 0.119s